POLITICO Pulse Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy.
- Novavax’s manufacturing challenges threaten global vaccine supplyby By Sarah Owermohle and Adam Cancryn on October 20, 2021 at 2:00 pm
The U.S. government invested $1.6 billion in Novavax in 2020 — the most it devoted to any vaccine maker at the time.
- Democrats squeeze some health priorities into funding billsby By Sarah Owermohle and Adam Cancryn on October 19, 2021 at 2:00 pm
The Labor-HHS bill repeals the Hyde and Weldon amendments, which have prevented Medicaid and other federal programs from covering abortions.
- States still struggling after federal Covid surgeby By Sarah Owermohle and Adam Cancryn on October 18, 2021 at 2:00 pm
States such as Alabama and Louisiana still are struggling with unsustainable Covid-19 caseloads that are stretching their funding.
- It’s J&J’s turn in the Covid-19 booster seatby By Adam Cancryn and Sarah Owermohle on October 15, 2021 at 2:06 pm
The White House is weighing the return of Robert Califf to run the Food and Drug Administration.
- The Covid-19 booster debate begins anewby By Adam Cancryn and Sarah Owermohle on October 14, 2021 at 2:00 pm
The session follows just a few weeks after the FDA authorized Pfizer and BioNTech’s booster amid a storm of controversy over the White House’s cheerleading of the extra dose and the quality of the data underpinning it.
WHO’s primary role is to direct international health within the United Nations’ system and to lead partners in global health responses.